Revisión de la Farmacoterapia en Pacientes Oncológicos en Cuidados Paliativos: el Farmacéutico en la Garantía del uso Racional y Seguro de los Medicamentos para el Control de los Síntomas
DOI:
https://doi.org/10.32635/2176-9745.RBC.2024v70n3.4695Palabras clave:
Revisión de Medicamentos, Deprescripciones, Oncología, Cuidados PaliativosResumen
Introducción: La revisión farmacoterapéutica consiste en analizar los fármacos utilizados por un paciente, con el objetivo de reducir los problemas relacionados con los medicamentos (PRM). El tratamiento paliativo puede provocar efectos adversos y contribuir a la polifarmacia. Por lo tanto, el farmacéutico es de gran valor para garantizar la seguridad y el uso racional asociado al tratamiento farmacológico. Objetivo: Analizar la revisión de la farmacoterapia realizada en pacientes con cáncer sometidos a cuidados paliativos exclusivos en un instituto de referencia de Río de Janeiro. Método: Estudio observacional, descriptivo, retrospectivo, con enfoque cuantitativo, que involucró a pacientes ingresados en la unidad de cuidados paliativos exclusivos del Instituto Nacional do Cáncer, quienes tuvieron su tratamiento farmacológico revisado por el farmacéutico, del 1 de junio de 2022 al 31 de mayo de 2023. Resultados: Se revisó el tratamiento farmacológico en 171 pacientes, la mayoría de sexo femenino (n=114; 66,7%) con edad igual o superior a los 60 años (n=104; 60,8%). Más de la mitad de los pacientes presentaron al menos una comorbilidad (n=93; 54,4%), con predominio de las relacionadas con el sistema circulatorio (n=68; 43,9%). El porcentaje de PRM y el porcentaje de intervenciones farmacéuticas arrojaron resultados equivalentes (23,4%). El PRM principal fue el uso de un medicamento que el paciente no necesitaba (n=49; 53,3%) y la mayoría de las intervenciones ocurrió para excluir medicamentos (n=55; 56,7%). Hubo 93,5% de aceptabilidad de las intervenciones. Conclusión: El estudio destaca la importancia de revisar la farmacoterapia para optimizar el tratamiento farmacológico en cuidados paliativos y refuerza la necesidad de reducir el número de medicamentos prescritos al final de la vida.
Descargas
Citas
Veras R. Envelhecimento populacional contemporâneo: demandas, desafios e inovações. Rev Saude Publica. 2009;43(3):548-54. doi: https://doi.org/10.1590/S0034-89102009005000025 DOI: https://doi.org/10.1590/S0034-89102009005000025
World Health Organization. Medication without harm – global patient safety challenge on medication safety [Internet]. Geneva: World Health Organization; 2017. [acesso 2023 abr 21]. Disponível em: https://iris.who.int/bitstream/handle/10665/255263/WHO-HIS-SDS-2017.6-eng.pdf?sequence=1
Pereira KG, Peres MA, Iop D, et al. Polifarmácia em idosos: um estudo de base populacional. Rev Bras Epidemiol. 2017;20(2):335-44. doi: https://doi.org/10.1590/1980-5497201700020013 DOI: https://doi.org/10.1590/1980-5497201700020013
Nascimento RCRM, Alvares J, Guerra-Junior AA, et al. Polifarmácia: uma realidade na atenção primária do Sistema Único de Saúde. Rev Saude Publica. 2017;51(Supl 2):19s. doi: https://doi.org/10.11606/S1518-8787.2017051007136 DOI: https://doi.org/10.11606/S1518-8787.2017051007136
Saraf AA, Petersen AW, Simmons SF, et al. Medications associated with geriatric syndromes and their prevalence in older hospitalized adults discharged to skilled nursing facilities. J Hosp Med. 2016;11(10):694-700. doi: https://doi.org/10.1002/jhm.2614 DOI: https://doi.org/10.1002/jhm.2614
World Health Organization. World alliance for patient safety, the research priority setting working group. Summary of the evidence on patient safety: implications for research [Internet]. Geneva: World Health Organization; 2008. [acesso 2023 nov 17]. Disponível em: https://iris.who.int/bitstream/handle/10665/43874/9789241596541_eng.pdf?sequence=1&isAllowed=y
Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;(2):CD008986. doi: https://doi.org/10.1002/14651858.cd008986.pub3 DOI: https://doi.org/10.1002/14651858.CD008986.pub3
Dautzenberg L, Bretagne L, Koek HL, et al. Medication review interventions to reduce hospital readmissions in older people. J Am Geriatr Soc. 2021;69:1646-58. doi: https://doi.org/10.1111/jgs.17041 DOI: https://doi.org/10.1111/jgs.17041
Clyne W, Blenkinsopp A, Seal R. A guide to medication review [Internet]. Liverpool: Keele University; NPC Plus & Medicines Partnership; 2008. [acesso 2023 out 14]. Disponível em: https://www.cff.org.br/userfiles/52%20-%20CLYNE%20W%20A%20guide%20to%20medication%20review%202008.pdf
Conselho Federal de Farmacia (BR). Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade: contextualização e arcabouço conceitual [Internet]. Brasília, DF: PROFAR; 2016. [acesso em 2023 dez 8]. Disponível em: https://www.cff.org.br/userfiles/Profar_Arcabouco_TELA_FINAL.pdf
National Institute for Health and Care Excellence. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes [Internet]. Manchester: NICE guideline; 2015. [acesso 2024 jan 23]. Disponível em: https://www.nice.org.uk/guidance/ng5/resources/medicines-optimisation-the-safe-and-effectiveuse-of-medicines-to-enable-the-best-possible-outcomespdf-51041805253
Beuscart JB, Pelayo S, Robert L, et al. Medication review and reconciliation in older adults. Eur Geriatr Med. 2021;(12):499-507. doi: https://doi.org/10.1007/s41999-021-00449-9 DOI: https://doi.org/10.1007/s41999-021-00449-9
Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74(4):573-80. doi: https://doi.org/10.1111/j.1365-2125.2012.04331.x DOI: https://doi.org/10.1111/j.1365-2125.2012.04331.x
Pharmaceutical Care Network Europe. Classification for drug related problems – Version 9.1 [Internet]. Zuidlaren: PCNE; 2020. [acesso 2023 maio 28]. Disponível em: https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf
Morin L, Johnell K, Laroche ML, et al. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;2018(10):289-98. doi: https://doi.org/10.2147/CLEP.S153458 DOI: https://doi.org/10.2147/CLEP.S153458
Auvinen KJ, Räisänen J, Voutilainen A, et al. Interprofessional medication assessment has effects on the quality of medication among home care patients: randomized controlled intervention study. J Am Med Dir Assoc. 2021;20(1):74-8. doi: https://doi.org/10.1016/j.jamda.2020.07.007 DOI: https://doi.org/10.1016/j.jamda.2020.07.007
World Health Organization. WHO definition of palliative care. Geneva: World Health Organization; 2019.
Conselho Regional de Farmácia (SP). São Paulo: CRFSP; 2000. Ministério da Saúde normatiza cuidados paliativosno SUS, 2018 nov 23. [acesso 2023 dez 15]. Disponível em: https://crfsp.org.br/noticias/10197-suscuidados-paliativos.html
Sociedade Brasileira de Geriatria e Gerontologia. Vamos falar de cuidados paliativos [Internet]. Rio de Janeiro: SBGG; 2015. [acesso 2023 jun 23]. Disponível em: https://sbgg.org.br/wp-content/uploads/2015/05/vamos-falar-de-cuidados-paliativos-vers--o-online.pdf
Bittencourt NCCM, Santos KA, Mesquita MGR, et al. Sinais e sintomas manifestados por pacientes em cuidados paliativos oncológicos na assistência domiciliar: uma revisão integrativa. Esc Anna Nery. 2021;25(4):e20200520. doi: https://doi.org/10.1590/2177-9465-EAN-2020-0520 DOI: https://doi.org/10.1590/2177-9465-ean-2020-0520
Rabelo ML, Borella MLL. Papel do farmacêutico no seguimento farmacoterapêutico para o controle da dor de origem oncológica. Rev Dor. 2013;14(1):58-60. doi: https://doi.org/10.1590/S1806-00132013000100014 DOI: https://doi.org/10.1590/S1806-00132013000100014
Conselho Nacional de Saúde (BR). Resolução CNS n.º 466/2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos e revoga as Resoluções CNS n.º 196/96, 303/2000 e 404/2008 Internet]. Diário Oficial da União, Brasília, DF. 2013 [acesso 2023 jul 12]; Seção I:59. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html
Gospodarowicz MK, Wittekind C, Brierley JD, editors. TNM: classificação de tumores malignos. Eisenberg ALA, tradução. 8. ed. Rio de Janeiro: INCA; 2022.
Giuliano AE, Connolly JL, Edge SB, et al. Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(4):290-303. doi: https://doi.org/10.3322/caac.21393 DOI: https://doi.org/10.3322/caac.21393
Wells RHC, Bay-Nielsen H, Braun R, et al. CID-10: classificação estatística internacional de doenças e problemas relacionados à saúde. São Paulo: EDUSP; 2011.
Karnofsky DA, Burchenal JH. Experimental observations on the effects of the nitrogen mustards on neoplastic tissues. Cancer Res. 1947;7(1):50.
Comité de Consenso. Segundo consenso de Granada sobre problemas relacionados con medicamentos. Ars Pharm [Internet]. 2002 [acesso 2023 nov 20];43(3-4):175-84. Disponível em: https://www.ugr.es/~ars/abstract/43-179-02.pdf
Otero-Lopez MJ, Castaño Rodríguez a B, PérezEncinas M, et.al. Updated classification for medication errors by the Ruiz-Jarabo 2000 Group. Farm Hosp. 2008;32(1):38-52. doi: https://doi.org/10.1016/s1130-6343(08)72808-3 DOI: https://doi.org/10.1016/S1130-6343(08)72808-3
StataR [Internet]. Versão 15.0. Lakeway: StataCorp LLC; 1996–2024c. [acesso 2023 nov 20]. Disponível em: https://www.stata.com/
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: https://doi.org/10.3322/caac.21492 DOI: https://doi.org/10.3322/caac.21492
Oliveira MBP, Souza NR, Bushatsky M, et al. Oncological homecare: family and caregiver perception of palliative care. Esc Anna Nery. 2017;21(2):e20170030. doi: https://doi.org/10.5935/1414-8145.20170030 DOI: https://doi.org/10.5935/1414-8145.20170030
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. doi: https://doi.org/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660
Wild CP, Weiderpass E, Stewart BW, editors. World cancer report: cancer research for cancer prevention [Internet]. Lyon: International Agency for Research on Cancer; 2020. [acesso 2024 fev 6]. Disponível em: https://www.iccp-portal.org/system/files/resources/IARC%20World%20Cancer%20Report%202020.pdf
Instituto Nacional de Câncer. Estimativa 2023: incidência de câncer no Brasil [Internet]. Rio de Janeiro: INCA; 2022. [acesso 2023 maio 22]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2023.pdf
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;1-35. doi: https://doi.org/10.3322/caac.21834 DOI: https://doi.org/10.3322/caac.21834
Oliveira MM, Malta DC, Guauche H, et al. Estimativa de pessoas com diagnóstico de câncer no Brasil: dados da Pesquisa Nacional de Saúde. 2013. Rev Bras Epidemiol. 2015;18:146-57. doi: https://doi.org/10.1590/1980-5497201500060013 DOI: https://doi.org/10.1590/1980-5497201500060013
Boakye D, Günther K, Niedermaier T, et al. Associations between comorbidities and advanced stage diagnosis of lung, breast, colorectal, and prostate cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2021;75:102054. doi: https://doi.org/10.1016/j.canep.2021.102054 DOI: https://doi.org/10.1016/j.canep.2021.102054
Han H, Guo W, Shi W, et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep. 2017;7:44877. doi: https://doi.org/10.1038/srep44877 DOI: https://doi.org/10.1038/srep44877
Krumm L, Bausewein C, Remi C. Drug therapy safety in palliative care - pharmaceutical analysis of medication processes in palliative care. Pharmacy (Basel). 2023;11(5):160. doi: https://doi.org/10.3390/pharmacy11050160 DOI: https://doi.org/10.3390/pharmacy11050160
Wernli U, Hischier D, Meier CR, et al. Pharmacists’ clinical roles and activities in inpatient hospice and palliative care: a scoping review. Int J Clin Pharm. 2023;45(3):577-86. doi: https://doi.org/10.1007/s11096-023-01535-7 DOI: https://doi.org/10.1007/s11096-023-01535-7
Peralta T, Castel-Branco MM, Reis-Pina P, et al. Prescription trends at the end of life in a palliative care unit: observational study. BMC Palliat Care. 2022; 21(1):65. doi: https://doi.org/10.1186/s12904-022-00954-z DOI: https://doi.org/10.1186/s12904-022-00954-z
Duncan I, Maxwell TL, Huynh N, et al. Polypharmacy, medication possession, and deprescribing of potentially non-beneficial drugs in hospice patients. Am J Hosp Palliat Med. 2020;37(12):1076-85. doi: https://doi.org/10.1177/1049909120939091 DOI: https://doi.org/10.1177/1049909120939091
Currow DC, Stevenson JP, Abernethy AP, et al.Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55(4):590-95. doi: https://doi.org/10.1111/j.1532-5415.2007.01124.x DOI: https://doi.org/10.1111/j.1532-5415.2007.01124.x
Van Nordennen RTCM, Lavrijsen JCM, Heesterbeek MJAB, et al. Changes in prescribed drugs between admission and the end of life in patients admitted palliative care facilities. J Am Med Dir Assoc. 2016;17(6):514-8. doi https://doi.org/10.1016/j.jamda.2016.01.015 DOI: https://doi.org/10.1016/j.jamda.2016.01.015
Publicado
Cómo citar
Número
Sección
Licencia
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
